Advertisement: TTP Killer 50
25 October, 2016 - 14:44 By News Desk


AstraZeneca Cambridge

The global science-led biopharma business whose medicines are used by millions of patients worldwide is creating an estimated 2,500 jobs at a new corporate HQ and R & D hub being built at the Cambridge Biomedical Campus and has driven several key partnerships with the university and influential biotech companies. 

AstraZeneca and its global biologics R & D arm, MedImmune, have also chosen Cambridge as the base for a new genomics research centre geared to transform drug discovery and development across its entire R & D pipeline.


Newsletter Subscription

Stay informed of the latest news and features